People with diabetes often experience abnormal blood fat levels, known as dyslipidemia, which increase the risk of heart disease and stroke. The aim of the study, researchers are exploring a natural and practical solution through a healthy snack in the form of cookies. These cookies are made from Golden Rice, which is rich in beta-carotene as a natural antioxidant, and Piper crocatum (red betel leaf) extract, which contains polyphenols and flavonoids that may help lower cholesterol, reduce inflammation, and protect blood vessels. In this study, patients with diabetes will consume the cookies for 28 days, and their blood fat levels will be measured before and after the intervention. The results will then be compared with those of a control group who receive the Golden rice cookies without piper crocatum extract. This research aims to show that Golden Rice with Piper crocatum extract cookies can reduce bad cholesterol and triglycerides, increase good cholesterol, and serve as a safe, affordable, and acceptable food option to support daily diabetes care. If successful, this approach may offer patients and families a simple way to help prevent complications and improve quality of life, alongside regular treatment and lifestyle changes.
This clinical trial evaluates the effect of Golden Rice cookies enriched with Piper crocatum (red betel leaf) extract on lipid profile control in patients with type 2 diabetes mellitus. The intervention is designed as a short-term, food-based strategy to complement existing diabetes management by integrating functional food into daily dietary practice. The rationale for this approach is based on evidence that beta-carotene from Golden Rice and polyphenols from Piper crocatum exert antioxidant, anti-inflammatory, and lipid-lowering activities. Combining these bioactive compounds in the form of cookies provides a culturally acceptable, affordable, and practical dietary intervention. The cookie format was selected due to its high acceptance, ease of distribution, and potential to improve adherence compared with capsule or extract preparations. This trial uses a controlled pre-post design to compare changes in lipid biomarkers between the intervention and control groups over 28 days. Key outcomes include serum levels of LDL cholesterol, HDL cholesterol, triglycerides, and total cholesterol. The study also explores potential synergistic effects on oxidative stress and inflammatory processes associated with dyslipidemia in diabetes. By translating the concept of functional food into a practical dietary item, this study aims to generate evidence for its role as an adjunctive therapy in diabetes care. Findings are expected to inform future dietary guidelines and nursing interventions, particularly in community-based settings where accessibility, patient adherence, and cost-effectiveness are critical considerations.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
102
Golden Rice cookies enriched with Piper crocatum extract, formulated as a functional food containing β-carotene and polyphenols with antioxidant, anti-inflammatory, and lipid-modulating properties. Participants will consume the cookies daily for 28 consecutive days in addition to their standard diabetes management. This intervention is designed to improve lipid metabolism and reduce dyslipidemia in patients with Diabetes Mellitus.
Placebo cookies without Golden Rice or Piper crocatum extract, identical in appearance, taste, and packaging to the intervention cookies. Participants will consume placebo cookies daily for 28 consecutive days along with their standard diabetes management. This placebo is used to maintain participant blinding and provide a valid comparison.
Tambu Primary Health Center (Puskesmas Tambu)
Donggala, Central Sulawesi, Indonesia
RSUD Anutapura Palu
Palu, Central Sulawesi, Indonesia
Change in total Cholesterol (mg/dL)
Serum total cholesterol will be measured to assess the effect of Golden Rice cookies enriched with Piper crocatum extract on lipid control in patients with diabetes mellitus.
Time frame: Baseline (Day 0) and after 28 days of intervention
Change in Low-Density Lipoprotein (LDL) Cholesterol (mg/dL)
LDL cholesterol levels will be measured to evaluate changes following the 28-day intervention
Time frame: Baseline (Day 0) to Day 28
Change in High-Density Lipoprotein (HDL) Cholesterol (mg/dL)
HDL cholesterol levels will be measured to determine improvement in protective lipid fractions.
Time frame: Baseline (Day 0) to Day 28
Change in Triglycerides (mg/dL)
Serum triglyceride levels will be measured to assess metabolic lipid response to the intervention.
Time frame: Baseline (Day 0) to Day 28
Participant adherence Rate (%)
Daily adherence to the assigned cookie regimen will be monitored using participant self-report checklists and confirmed by the count of returned empty packaging during weekly follow-up visits. Adherence will be reported as the percentage of prescribed doses consumed over the 28-day intervention.
Time frame: Baseline to Day 28
Incidence of Adverse Events (Number of Participants)
All adverse events and signs of intolerance (e.g., gastrointestinal symptoms, allergic reactions) potentially associated with the intervention will be documented throughout the study period. Events will be classified by type, severity, onset, duration, and relationship to the study product. Results will be reported as the number and percentage of participants experiencing at least one adverse event.
Time frame: Baseline to Day 28
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.